IP InterviewPublished July 30, 2025
Aldevron: mRNA, Plasmids and Synthetic DNA
inpractise.com/articles/aldevron-mrna-plasmids-and-synthetic-dna
Executive Bio
Former VP of Sales, Aldevron
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content
Medpace Holdings: Key Considerations in Selecting a CRO
Current VP of Clinical Operations at Biotech Company
Cytiva vs Sartorius: A Vaccine Customer's Perspective
Vaccine Manufacturing Lead at Sanofi
Bruker and AI Applications in Mass Spectrometry
Former Director of Bruker
Porvair & Chromatography Lab Equipment: M&A Process & Culture
Former Senior Vice President Life Sciences at J.G. Finneran, Porvair plc
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.